Skip to main content
Top
Published in: International Journal of Clinical Pharmacy 1/2024

09-01-2024 | Abstract

51st ESCP symposium on clinical pharmacy 31 October–02 November 2023, Aberdeen, Scotland

Innovations in clinical pharmacy practice, education and research

Published in: International Journal of Clinical Pharmacy | Issue 1/2024

Login to get access

Excerpt

1Utrecht Institute of Pharmaceutical Sciences, Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht University, Utrecht, Netherlands, 2Department of Pharmacy, Uppsala University, Uppsala, Sweden, 3Nivel, Netherlands Institute for Health Services Research, 4Department of General Practice, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, 5SIR Institute for Pharmacy Practice and Policy, Leiden, Netherlands, 6College of Pharmacy, Qatar University, Doha, Qatar, 7Department of Pharmacotherapy, -Epidemiology and -Economics, University of Groningen, Groningen, Netherlands …
Metadata
Title
51st ESCP symposium on clinical pharmacy 31 October–02 November 2023, Aberdeen, Scotland
Innovations in clinical pharmacy practice, education and research
Publication date
09-01-2024
Publisher
Springer International Publishing
Published in
International Journal of Clinical Pharmacy / Issue 1/2024
Print ISSN: 2210-7703
Electronic ISSN: 2210-7711
DOI
https://doi.org/10.1007/s11096-023-01685-8

Other articles of this Issue 1/2024

International Journal of Clinical Pharmacy 1/2024 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine